Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
- 23 September 2011
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 32 (12), 700-707
- https://doi.org/10.1016/j.tips.2011.08.002
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Novel HDL-directed pharmacotherapeutic strategiesNature Reviews Cardiology, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic AcidCell Metabolism, 2010
- Blockade of Dendritic Cell Development by Bacterial Fermentation Products Butyrate and Propionate through a Transporter (Slc5a8)-dependent Inhibition of Histone DeacetylasesJournal of Biological Chemistry, 2010
- Niaspan treatment induces neuroprotection after strokeNeurobiology of Disease, 2010
- Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectinAtherosclerosis, 2009
- The mechanism and mitigation of niacin-induced flushingInternational Journal Of Clinical Practice, 2009
- Nicotinic acid: an old drug with a promising futureBritish Journal of Pharmacology, 2008
- Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltrationClinical and Experimental Immunology, 2006
- Antagonism of the prostaglandin D 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humansProceedings of the National Academy of Sciences, 2006